(Q38036543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

3

Soldano Ferrone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Janelle M Fauci

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

J Michael Straughn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

19 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

420-425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

The control of T cell activation vs. tolerance

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Prognostic and predictive impact of intra- and peritumoral immune infiltrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Immunologic nonresponsiveness to tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

The B7 family of immune-regulatory ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

The complex role of B7 molecules in tumor immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H3 regulates the development of experimental allergic conjunctivitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H3 contributes to the development of pathogenic Th2 cells in a murine model of asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Clinical importance of B7-H3 expression in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7x: a widely expressed B7 family member that inhibits T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

BTLA: a new inhibitory receptor with a B7-like ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7S1, a novel B7 family member that negatively regulates T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-h4 is highly expressed in ductal and lobular breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H4 expression promotes tumorigenesis in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H4 overexpression in ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.08.017

10.1016/J.YGYNO.2012.08.017

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22910694%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference